HSBC Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.9K | Sell |
16,573
-20,863
| -56% | -$108K | ﹤0.01% | 2400 |
|
|
2025
Q1 | $197K | Buy |
37,436
+1,097
| +3% | +$5.77K | ﹤0.01% | 2180 |
|
|
2024
Q4 | $249K | Buy |
36,339
+11,822
| +48% | +$81.1K | ﹤0.01% | 2186 |
|
|
2024
Q3 | $164K | Sell |
24,517
-3,455
| -12% | -$23.2K | ﹤0.01% | 2309 |
|
|
2024
Q2 | $206K | Buy |
27,972
+5,764
| +26% | +$42.5K | ﹤0.01% | 2179 |
|
|
2024
Q1 | $221K | Buy |
+22,208
| New | +$221K | ﹤0.01% | 2223 |
|
|
2023
Q3 | – | Sell |
-19,495
| Closed | -$148K | – | 2258 |
|
|
2023
Q2 | $148K | Buy |
19,495
+9,004
| +86% | +$68.5K | ﹤0.01% | 1955 |
|
|
2023
Q1 | $70.3K | Buy |
10,491
+290
| +3% | +$1.94K | ﹤0.01% | 2107 |
|
|
2022
Q4 | $76.3K | Hold |
10,201
| – | – | ﹤0.01% | 2451 |
|
|
2022
Q3 | $111K | Sell |
10,201
-2,870
| -22% | -$31.2K | ﹤0.01% | 2291 |
|
|
2022
Q2 | $105K | Buy |
+13,071
| New | +$105K | ﹤0.01% | 2595 |
|